Biosimilars Provision In Pacific Trade Deal Adds Fuel To Generic Fight
This article was originally published in The Pink Sheet Daily
Executive Summary
As negotiations over Trans-Pacific Partnership Agreement near completion, generic drug advocates make all-out push to eliminate IP provisions, particularly one they say would create patent linkage for biologics.